(19)
(11) EP 0 998 570 A1

(12)

(43) Date of publication:
10.05.2000 Bulletin 2000/19

(21) Application number: 98933404.0

(22) Date of filing: 10.07.1998
(51) International Patent Classification (IPC)7: C12N 15/57, C12N 9/52, A61K 38/48, A61K 48/00, C12N 15/87
(86) International application number:
PCT/CA9800/679
(87) International publication number:
WO 9905/289 (04.02.1999 Gazette 1999/05)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.07.1997 CA 2211293

(71) Applicant: Immunova LTEE.
Sainte-Foy,Québec G1V 4T3 (CA)

(72) Inventors:
  • GAGNE, Marc
    St-Jean-Chrysostome, Québec G6Z 2S8 (CA)
  • CHAPDELAINE, Pierre
    Saint-Romuald, Québec G6W 3C4 (CA)
  • THERRIEN, Jacinthe
    Saint-Théophile, Québec G0M 2A0 (CA)
  • GAGNE, Dominic
    Loretteville, Québec G2B 3C4 (CA)

(74) Representative: Keller, Günter, Dr. et al
Lederer, Keller & RiedererPatentanwältePrinzregentenstrasse 16
80538 München
80538 München (DE)

   


(54) RECOMBINANT LYSOSTAPHIN ANALOGS